One year in review 2018: idiopathic inflammatory myopathies

Clin Exp Rheumatol. 2018 Nov-Dec;36(6):937-947. Epub 2018 Dec 6.

Abstract

Idiopathic inflammatory myopathies (IIMs) are a group of chronic autoimmune systemic diseases affecting the skeletal muscle and other organs. IIMs are also a complex group of diseases, in some cases, difficult to manage. Literature on IIMs has been growing fairly rapidly and keeping up-to-date on such a topic is of utmost importance for any rheumatologist who looks after IIM patients. Thus, the aim of this review is to summarise the most relevant literature contributions published over the last year on the pathogenesis, serology, diagnosis and treatment of IIMs.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Autoantibodies / blood
  • Autoantibodies / immunology
  • Autoimmunity
  • Biomarkers / blood
  • Humans
  • Myositis* / blood
  • Myositis* / diagnostic imaging
  • Myositis* / immunology
  • Myositis* / therapy
  • Predictive Value of Tests
  • Risk Factors
  • Serologic Tests
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Autoantibodies
  • Biomarkers